Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
prostate-cancer
prostate cancer, metastatic castration-resistant prostate cancer, enzalutamide, ly2157299, tgf-β receptor inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 835992
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.